Results 211 to 220 of about 383,105 (350)

[Propafenone as an anti-arrhythmia agent].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 1987
A, Tomaszewski, A, Kleinrok, M, Markiewicz   +2 more
openaire   +1 more source

Impact of catheter ablation for ventricular tachycardia on left ventricular ejection fraction in patients with structural heart disease

Journal of Arrhythmia, Volume 41, Issue 2, April 2025.
This study investigates the left ventricular ejection fraction (LVEF) before and after catheter ablation for ventricular tachycardia in patients with structural heart disease. Patients with severely impaired pre‐ablation LVEF demonstrated mild restoration in LVEF following ablation.
Ashish Sood, Samual Turnbull, Kasun De Silva, Ashwin Bhaskaran, Richard G. Bennett, Timothy G. Campbell, Liza Thomas, Saurabh Kumar   +7 more
wiley   +1 more source

Implications of Heart Failure Treatment on Atrial Fibrillation Onset: A Retrospective Study. [PDF]

Medicina (Kaunas)
Suhov L, Apostol A, Dăniluc L, Haj Ali L, Sandu OE, Bogdan C, Andor M.   +6 more
europepmc   +1 more source

Ion channels: too complex for rational drug design? [PDF]

, 1996
Colatsky, TJ, Goldstein, SA
core   +1 more source

Radiofrequency or cryoablation or medical therapy for paroxysmal atrial fibrillation: An indirect comparison of effectiveness

Journal of Arrhythmia, Volume 41, Issue 2, April 2025.
This study demonstrates that both cryoballoon and radiofrequency ablation are significantly more effective than anti‐arrhythmic drugs in reducing arrhythmia recurrence as first‐line therapy for paroxysmal atrial fibrillation, supporting ablation as the preferred initial treatment strategy.
Roberto Brunoro, Lorenzo Di Spazio, Melania Rivano, Luca Cancanelli, Chiara Nunzia Fasano Celentano, Daniele Mengato, Andrea Messori   +6 more
wiley   +1 more source

The Prognostic Value of Circulating Cytokines and Complete Blood Count-Based Inflammatory Markers in COVID-19 Patients With Atrial Fibrillation. [PDF]

Cardiol Res
Tcholadze G, Pantsulaia I, Ratiani L, Kopaleishvili L, Bolotashvili T, Jorbenadze A, Chikovani T.   +6 more
europepmc   +1 more source

Effectiveness of Paroxetine Versus Non‐Paroxetine Selective Serotonin Reuptake Inhibitors on Mortality and Heart Failure Following Myocardial Infarction: An Active Comparator Population‐Based Cohort Study

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 4, April 2025.
ABSTRACT Background Animal studies suggest that paroxetine, unlike other selective serotonin reuptake inhibitors (SSRIs), may attenuate post‐myocardial infarction (MI) heart failure. We examine the effectiveness of paroxetine versus non‐paroxetine SSRIs on the risk of post‐MI mortality and heart failure in a clinical setting.
Thomas Ravn Lassen, Péter Szentkúti, Henrik Toft Sørensen, Hans Erik Bøtker, Jens Sundbøll   +4 more
wiley   +1 more source

Management Status of Myocarditis-Related Sudden Cardiac Death. [PDF]

Rev Cardiovasc Med
Yan P, Yang S, Wang T.
europepmc   +1 more source

Analysis of Reporting Trends of Serious Adverse Events Associated With Anti‐Obesity Drugs

Pharmacology Research &Perspectives, Volume 13, Issue 2, April 2025.
ABSTRACT Concern over the side effects of anti‐obesity medications, particularly if severe, has grown as their use has increased. Thus, the objective was to use trends in the reporting of suspected adverse events associated with anti‐obesity medications that have been approved for sale in the European Union to attempt to uncover discrepancies in the ...
Branislava B. Raičević, Andrej Belančić, Nikola Mirković, Slobodan M. Janković   +3 more
wiley   +1 more source

Risk, rate or rhythm control for new onset supraventricular arrhythmia during septic shock: protocol for the CAFS multicentre, parallel-group, open-label trial. [PDF]

BMJ Open
Labbé V, Desnos C, Preau S, Doyen D, Contou D, Bagate F, Souweine B, Pey V, Bertrand PM, Müller G, Boissier F, Asfar P, Bonnet N, Joffre J, Sy O, Dres M, Annoni F, Monnet X, Carreira S, Vivier E, Serck N, Wiart A, Voicu S, Heming N, Le Breton C, Chevrel G, Chemouni F, Piagnerelli M, Haentjens L, Fartoukh M, Taccone F, Durand D, Monthieux G, Berard L, Rousseau A, Mekontso Dessap A.   +35 more
europepmc   +1 more source